SYLLABUS Table of Contents CME Information / 2 Faculty / 4 Faculty Biographies / 11
Total Page:16
File Type:pdf, Size:1020Kb
25th Annual International AF SymposiumTM 2020 20 SYLLABUS Table of Contents CME Information / 2 Faculty / 4 Faculty Biographies / 11 25th Annual International AF Symposium 2020 January 23-25, 2020 CME Information Jointly provided by Postgraduate Institute for Medicine and Advanced Medical Education This activity is supported by an independent educational grant from Boston Scientific, Biosense Webster, Medtronic, and Abbott TARGET AUDIENCE This activity has been designed to meet the educational needs of cardiologists, internists, fellows, physician assistants, registered nurses, nurse practitioners, and other medical professionals involved in the care of patients with atrial fibrillation. EDUCATIONAL OBJECTIVES After completing this activity, the participant should be better able to: 1. Provide a current review of new information on the clinical science and pathophysiology of atrial fibrillation and atrial fibrillation-related stroke 2. Provide a detailed presentation of the most recent developments in the diagnosis and treatment of atrial fibrillation 3. Discuss the prevention of AF-related stroke and other sequelae, with an emphasis on current and evolving pharmacological and nonpharmacological therapies and enabling new technologies in the field of cardiac electrophysiology 4. Exchange thoughts and techniques with the treatment team to improve the outcome of patient care and treatment 5. Provide appropriate care and counsel for patients and their families through the education of healthcare professionals JOINT ACCREDITATION STATEMENT In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Advanced Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 2 CME Information PHYSICIAN CONTINUING MEDICAL EDUCATION The Postgraduate Institute for Medicine designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CONTINUING NURSING EDUCATION The maximum number of hours awarded for this Continuing Nursing Education activity is 15 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate. MOC STATEMENT Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.25 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. DISCLOSURE OF CONFLICTS OF INTEREST Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. 3 Faculty Amin Al-Ahmad, MD States the following: Consulting Fees (e.g., advisory boards): Boston Scientific, Biosense Webster, Abbott, Cardiva Hugh Calkins, MD States the following: Consulting Fees (e.g., advisory boards): Biosense, Medtronic, Atricure, Boston Scientific, Abbott Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers’ bureaus):Medtronic, Biosense A. John Camm, MD States the following: Consulting Fees (e.g., advisory boards): Bayer, Daiichi Sankyo, Boston Scientific, Sanofi, Acesion, Correvio Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers’ bureaus): Bayer, Daiichi Sankyo, Boston Scientific, Sanofi, Acesion, Correvio Contracted Research: Bayer, Boehringer Ingelheim, Pfizer, aiichiD Sankyo, Abbott Stuart Connolly, MD States the following: Consulting Fees (e.g., advisory boards): Sanofi Aventis, Bayer, Portola, Boston Scientific, Javelin, Boehringer-Ingelheim, Bristol-Myers Squibb Contracted Research: Sanofi Aventis, Bayer, Boston Scientific, Boehringer-Ingelheim, Bristol-Myers Squibb Isabel Deisenhofer, MD States the following: Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers’ bureaus): Abbott, Biosense-Webster, Boston-Scientific (Speaker honoraria) Thomas Deneke, MD States the following: Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers’ bureaus): Speakers activity (Biotronik, Abbott), total amound 3.000 Luigi Di Biase, MD, PhD States the following: Consulting Fees (e.g., advisory boards): Biosense Webster, Stereotaxis, Abbott Speaker Honoraria, Travel Support: Biotronik, Medtronic, Boston Scientific, Bristol Meyers Squibb and PFizer. Jun Dong, MD States the following: Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months Patrick Ellinor, MD, PhD States the following: Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months Andrew Farb, MD States the following: Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months 4 John Foran, MD States the following: Other: Proctoring Paul Friedman, MD States the following: Receipt of Intellectual Property Rights/Patent Holder : NeoChord, Preventice, Sorin, AliveCor, Champion Medical, Apervita, Eko Consulting Fees (e.g., advisory boards): Medtronic, Boston Scientific Contracted Research: St. Jude Medical Other: AliveCor and Eko- Mayo Clinic has licensed IP to AliveCor and Eko and I may benefit from its commercialization, but not when used for patients at Mayo Clinic Mahmut Gurol, MD, MSc States the following: Other: Research Support (Investigator Sponsored) Avid, Pfizer, Boston Scientific Michel Haissaguerre, MD Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months Kevin Heist, MD, PhD States the following: Consulting Fees (e.g., advisory boards): Biotronik, Boston Scientific, Abbott, Pfizer Ownership Interest less than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds): Oracle Health (non-public startup) Rodney Horton, MD States the following: Consulting Fees (e.g., advisory boards): Boston Scientific, Biosense Webster, Abbott Elaine Hylek, MD, MPH States the following: Consulting Fees (e.g., advisory boards): Bistol Myers Squibb/Pfizer, Medtronic Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers’ bureaus):Boehringer Ingelheim, BMS/PFizer Contracted Research: Abbott, Janssen Pierre Jais, MD States the following: Consulting Fees (e.g., advisory boards): BSC, Farapulse Ownership Interest less than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds): Farapulse Jose Jalife, MD States the following: Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months David Keane, MD, PhD States the following: Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months Young-Hoon Kim, MD, PhD States the following: Hereby states that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months 5 Bradley Knight, MD States the following: Consulting Fees (e.g., advisory boards): BSCI, MDT, Abbott, Baylis, Biotronik Hans Kottkamp, MD States the following: Contracted Research: Kardium Ownership Interest less than 5% (stocks, stock options, or other ownership interest excluding diversified mutual funds):Kardium Karl-Heinz Kuck, MD States the following: Consulting Fees (e.g., advisory boards): Biosense Webster, Biotronik, Impulse Dynamics, Abott Vascular Dhanunjaya Lakkireddy, MD States the following: Consulting Fees (e.g., advisory boards): Janssen, Biotronik, Biosense Webster,